False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials
Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research & potential conflicts between the principles of scientific methodology & those of patients' best interests. The emotional &...
Gespeichert in:
Veröffentlicht in: | The Hastings Center report 1987-04, Vol.17 (2), p.16-19 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 19 |
---|---|
container_issue | 2 |
container_start_page | 16 |
container_title | The Hastings Center report |
container_volume | 17 |
creator | Vanderpool, Harold Y. Weiss, Gary B. |
description | Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research & potential conflicts between the principles of scientific methodology & those of patients' best interests. The emotional & social context of cancer research make it extremely tempting for MDs to lie or manipulate data on some patients regarding their eligibility to enter into clinical trials of investigational drugs. The issue of whether such deception is justified for the sake of possibly prolonging a patient's life is explored. It is concluded that allowing ineligible candidates into such research may render the results misleading or meaningless. Some suggestions are provided to relieve researchers' ethical tensions regarding these patients, eg, providing treatment outside the clinical research setting. Modified HA |
doi_str_mv | 10.2307/3562037 |
format | Article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_60970633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>3562037</jstor_id><sourcerecordid>3562037</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1583-17143026dad6a69b0a3763e3874337235fffd354c835798dd4677554861fc02f3</originalsourceid><addsrcrecordid>eNp10E1LAzEQBuAgCtYq_oWAoqfVJJOv9Sa1tcWCHip4W9LdbElJszXZHvz3prQnwbnMYR5ehheha0oeGBD1CEIyAuoEDagQrKBcfp2iASElFASAn6OLlNYkD9cwQG8T45PFL6Y32IQGz03q8bTb2vSExyF23ruwwrNgvVu5pbf4w_TOhj5hF_AoH11tPF5El2Mu0Vm7T7s67iH6nIwXo2kxf3-djZ7nRU2FhoIqyoEw2ZhGGlkuiQElwYJWHEAxEG3bNiB4rUGoUjcNl0oJwbWkbU1YC0N0d8jdxu57Z1NfbVyqrfcm2G6XKklKRSRAhjd_4LrbxZB_qygrGSVaS5nV_UHVsUsp2rbaRrcx8aeipNpXWh0rzfL2INep7-K_7BdYT2_H</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1292108866</pqid></control><display><type>article</type><title>False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials</title><source>Jstor Complete Legacy</source><source>Sociological Abstracts</source><source>Periodicals Index Online</source><creator>Vanderpool, Harold Y. ; Weiss, Gary B.</creator><creatorcontrib>Vanderpool, Harold Y. ; Weiss, Gary B.</creatorcontrib><description>Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research & potential conflicts between the principles of scientific methodology & those of patients' best interests. The emotional & social context of cancer research make it extremely tempting for MDs to lie or manipulate data on some patients regarding their eligibility to enter into clinical trials of investigational drugs. The issue of whether such deception is justified for the sake of possibly prolonging a patient's life is explored. It is concluded that allowing ineligible candidates into such research may render the results misleading or meaningless. Some suggestions are provided to relieve researchers' ethical tensions regarding these patients, eg, providing treatment outside the clinical research setting. Modified HA</description><identifier>ISSN: 0093-0334</identifier><identifier>EISSN: 1552-146X</identifier><identifier>DOI: 10.2307/3562037</identifier><identifier>CODEN: HSCRAS</identifier><language>eng</language><publisher>Hastings-on-Hudson, N.Y: The Hastings Center</publisher><subject>Cancer ; Clinical trials ; Ethical justification ; Experimentation ; False Data & the Therapeutic Misconception: Two Urgent Problems in Research Ethics ; Hope ; Life expectancy ; Medical Research ; Moral judgment ; Morality ; Patients ; Physicians ; Professional Ethics ; Research ethics ; Researcher Subject Relations ; Respect</subject><ispartof>The Hastings Center report, 1987-04, Vol.17 (2), p.16-19</ispartof><rights>Copyright 1987 The Hastings Center</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1583-17143026dad6a69b0a3763e3874337235fffd354c835798dd4677554861fc02f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3562037$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3562037$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27846,27901,27902,33752,57992,58225</link.rule.ids></links><search><creatorcontrib>Vanderpool, Harold Y.</creatorcontrib><creatorcontrib>Weiss, Gary B.</creatorcontrib><title>False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials</title><title>The Hastings Center report</title><description>Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research & potential conflicts between the principles of scientific methodology & those of patients' best interests. The emotional & social context of cancer research make it extremely tempting for MDs to lie or manipulate data on some patients regarding their eligibility to enter into clinical trials of investigational drugs. The issue of whether such deception is justified for the sake of possibly prolonging a patient's life is explored. It is concluded that allowing ineligible candidates into such research may render the results misleading or meaningless. Some suggestions are provided to relieve researchers' ethical tensions regarding these patients, eg, providing treatment outside the clinical research setting. Modified HA</description><subject>Cancer</subject><subject>Clinical trials</subject><subject>Ethical justification</subject><subject>Experimentation</subject><subject>False Data & the Therapeutic Misconception: Two Urgent Problems in Research Ethics</subject><subject>Hope</subject><subject>Life expectancy</subject><subject>Medical Research</subject><subject>Moral judgment</subject><subject>Morality</subject><subject>Patients</subject><subject>Physicians</subject><subject>Professional Ethics</subject><subject>Research ethics</subject><subject>Researcher Subject Relations</subject><subject>Respect</subject><issn>0093-0334</issn><issn>1552-146X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>K30</sourceid><sourceid>BHHNA</sourceid><recordid>eNp10E1LAzEQBuAgCtYq_oWAoqfVJJOv9Sa1tcWCHip4W9LdbElJszXZHvz3prQnwbnMYR5ehheha0oeGBD1CEIyAuoEDagQrKBcfp2iASElFASAn6OLlNYkD9cwQG8T45PFL6Y32IQGz03q8bTb2vSExyF23ruwwrNgvVu5pbf4w_TOhj5hF_AoH11tPF5El2Mu0Vm7T7s67iH6nIwXo2kxf3-djZ7nRU2FhoIqyoEw2ZhGGlkuiQElwYJWHEAxEG3bNiB4rUGoUjcNl0oJwbWkbU1YC0N0d8jdxu57Z1NfbVyqrfcm2G6XKklKRSRAhjd_4LrbxZB_qygrGSVaS5nV_UHVsUsp2rbaRrcx8aeipNpXWh0rzfL2INep7-K_7BdYT2_H</recordid><startdate>19870401</startdate><enddate>19870401</enddate><creator>Vanderpool, Harold Y.</creator><creator>Weiss, Gary B.</creator><general>The Hastings Center</general><general>Institute of Society, Ethics and the Life Sciences</general><scope>AAYXX</scope><scope>CITATION</scope><scope>JQCIK</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>7U4</scope><scope>BHHNA</scope><scope>DWI</scope><scope>WZK</scope></search><sort><creationdate>19870401</creationdate><title>False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials</title><author>Vanderpool, Harold Y. ; Weiss, Gary B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1583-17143026dad6a69b0a3763e3874337235fffd354c835798dd4677554861fc02f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Cancer</topic><topic>Clinical trials</topic><topic>Ethical justification</topic><topic>Experimentation</topic><topic>False Data & the Therapeutic Misconception: Two Urgent Problems in Research Ethics</topic><topic>Hope</topic><topic>Life expectancy</topic><topic>Medical Research</topic><topic>Moral judgment</topic><topic>Morality</topic><topic>Patients</topic><topic>Physicians</topic><topic>Professional Ethics</topic><topic>Research ethics</topic><topic>Researcher Subject Relations</topic><topic>Respect</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vanderpool, Harold Y.</creatorcontrib><creatorcontrib>Weiss, Gary B.</creatorcontrib><collection>CrossRef</collection><collection>Periodicals Index Online Segment 33</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>Sociological Abstracts (pre-2017)</collection><collection>Sociological Abstracts</collection><collection>Sociological Abstracts</collection><collection>Sociological Abstracts (Ovid)</collection><jtitle>The Hastings Center report</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vanderpool, Harold Y.</au><au>Weiss, Gary B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials</atitle><jtitle>The Hastings Center report</jtitle><date>1987-04-01</date><risdate>1987</risdate><volume>17</volume><issue>2</issue><spage>16</spage><epage>19</epage><pages>16-19</pages><issn>0093-0334</issn><eissn>1552-146X</eissn><coden>HSCRAS</coden><abstract>Despite the 1966 US Public Health Service's Directive on Human Experimentation, many unresolved issues remain surrounding the use of human Ss in research & potential conflicts between the principles of scientific methodology & those of patients' best interests. The emotional & social context of cancer research make it extremely tempting for MDs to lie or manipulate data on some patients regarding their eligibility to enter into clinical trials of investigational drugs. The issue of whether such deception is justified for the sake of possibly prolonging a patient's life is explored. It is concluded that allowing ineligible candidates into such research may render the results misleading or meaningless. Some suggestions are provided to relieve researchers' ethical tensions regarding these patients, eg, providing treatment outside the clinical research setting. Modified HA</abstract><cop>Hastings-on-Hudson, N.Y</cop><pub>The Hastings Center</pub><doi>10.2307/3562037</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0093-0334 |
ispartof | The Hastings Center report, 1987-04, Vol.17 (2), p.16-19 |
issn | 0093-0334 1552-146X |
language | eng |
recordid | cdi_proquest_miscellaneous_60970633 |
source | Jstor Complete Legacy; Sociological Abstracts; Periodicals Index Online |
subjects | Cancer Clinical trials Ethical justification Experimentation False Data & the Therapeutic Misconception: Two Urgent Problems in Research Ethics Hope Life expectancy Medical Research Moral judgment Morality Patients Physicians Professional Ethics Research ethics Researcher Subject Relations Respect |
title | False Data and Last Hopes: Enrolling Ineligible Patients in Clinical Trials |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T18%3A47%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=False%20Data%20and%20Last%20Hopes:%20Enrolling%20Ineligible%20Patients%20in%20Clinical%20Trials&rft.jtitle=The%20Hastings%20Center%20report&rft.au=Vanderpool,%20Harold%20Y.&rft.date=1987-04-01&rft.volume=17&rft.issue=2&rft.spage=16&rft.epage=19&rft.pages=16-19&rft.issn=0093-0334&rft.eissn=1552-146X&rft.coden=HSCRAS&rft_id=info:doi/10.2307/3562037&rft_dat=%3Cjstor_proqu%3E3562037%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1292108866&rft_id=info:pmid/&rft_jstor_id=3562037&rfr_iscdi=true |